B. Chen et al., Lithium and valproate differentially regulate brain regional expression ofphosphorylated CREB and c-Fos, MOL BRAIN R, 70(1), 1999, pp. 45-53
Previous studies in our laboratory have shown that the mood stabilizers, li
thium and valproate (VPA), regulate the transcription factors, cyclic AMP r
esponsive element binding protein (CREB), c-Fos and c-Jun, differentially i
n cultured human neuroblastoma SH-SY5Y cells. Here, we confirm these findin
gs in rat brain and further study the brain-regional effects of these drugs
using immunohistochemistry. We found that although chronic treatment with
LiCl or VPA did not change the expression of c-Fos and c-Jun, acute treatme
nt with either drugs increased c-Fos expression but not c-Jun expression in
CA1 and CA3 regions of hippocampus. Chronic treatment with LiCl, but not V
PA, decreased CREB phosphorylation in rat cerebral cortex and hippocampus.
These results suggest that lithium and VPA may act on different pathways to
bring about their long-term prophylactic effects on bipolar disorder (BD).
The regulation of CREB phosphorylation may be relevant to lithium effect.
VPA, which is also effective in ED, may be linked to other pathways. (C) 19
99 Published by Elsevier Science B.V. All rights reserved.